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Mineralization of Hydrogels for Bone Regeneration
Katerina Gkioni, M.Sc.,1 Sander C.G. Leeuwenburgh, Ph.D.,1 Timothy E.L. Douglas, Ph.D.,1
Antonios G. Mikos, Ph.D.,2 and John A. Jansen, D.D.S., Ph.D.1
Hydrogels are an important class of highly hydrated polymers that are widely investigated for potential use in
soft tissue engineering. Generally, however, hydrogels lack the ability to mineralize, preventing the formation of
chemical bonds with hard tissues such as bone. A recent trend in tissue engineering involves the development of
hydrogels that possess the capacity to mineralize. The strategy that has attracted most interest has been the
incorporation of inorganic phases such as calcium phosphate ceramics and bioglasses into hydrogel matrices.
These inorganic particles act as nucleation sites that enable further mineralization, thus improving the me-
chanical properties of the composite material. A second route to create nucleation sites for calcification of
hydrogels involves the use of features from the physiological mineralization process. Examples of these bio-
mimetic mineralization strategies include (1) soaking of hydrogels in solutions that are saturated with respect to
calcium phosphate, (2) incorporation of enzymes that catalyze deposition of bone mineral, and (3) incorporation
of synthetic analogues to matrix vesicles that are the initial sites of biomineralization. Functionalization of the
polymeric hydrogel backbone with negatively charged groups is a third mechanism to promote mineralization
in otherwise inert hydrogels. This review summarizes the main strategies that have been developed in the past
decade to calcify hydrogel matrices and render these hydrogels suitable for applications in bone regeneration.
Introduction
Bone substitution materials
Bone is a composite material comprised of a collage-nous fibrous matrix that is enriched with platelet-shaped
nanocrystals of carbonated apatite (average dimensions:
50 nm long, 25 nm wide, and 3nm thick). This complex na-
nostructure makes bone a unique tissue with exceptional
mechanical and biological properties.1,2
Despite several decades of research on synthetic bone
substitutes, the use of autografts is still the gold standard in
clinical practice. Autografting requires a surgery in which
parts of healthy bone from the patient are harvested from,
for instance, the iliac crest and subsequently transferred to
the site of application. Alternative options include the use of
bone harvested from another donor (allografts) or from an-
imals (xenografts).3,4 Even though these surgical treatments
have resulted into good clinical outcome, they are accom-
panied by strong drawbacks such as infections, pain, and
morbidity at the donor site, high costs, and the necessity of
additional surgery.5,6 To eliminate these severe problems,
there is a pressing need for novel synthetic materials that can
substitute bone sufficiently.
Several materials, such as metals7, ceramics, and poly-
mers8, have been used for bone replacement. In the era of
regenerative medicine, the poor degradability of metallic and
ceramic scaffolds has become the major disadvantage that
inhibits complete regeneration of bone tissue. Polymers, on
the other hand, are known for the ease by which degradation
can be tailored by controlling the chemical composition
of the monomer units during synthesis. Until recently, the
majority of polymeric bone substitutes were premade con-
structs that were implanted surgically via invasive surgery.
Clinically, there is a growing need for materials that can be
inserted using minimally invasive methods such as a simple
injection.9 Ideally, such a material should be of viscosity low
enough to be injected and harden after injection, thereby
enabling incorporation of drugs, cells, and growth factors in
the viscous solution before administration.10 Hydrogels are a
specific, highly hydrated class of polymers that fulfill all of
the abovementioned requirements.
Hydrogels
Hydrogels are hydrophilic crosslinked polymers that are
formed by the reaction of one or more monomers, by associ-
ation of hydrogen bonds or van der Waals interactions be-
tween the chains.11,12 The crosslinking can be achieved either
physically or chemically. While in chemical crosslinking co-
valent bonds must be formed, physical crosslinking happens
when physical interaction between the chains occurs.13
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Hydrogels can be classified according to their origin (natural
or synthetic),14 method of preparation (homopolymer, co-
polymer, multipolymer, and interpenetrating hydrogels), io-
nic charges (neutral, anionic, cationic, and ampholytic
hydrogels), and physical structure (amorphous, semicrystal-
line, and hydrogen bonded structures).11
When hydrogels are in contact with water, they swell and
form an insoluble three-dimensional network. Other than
injectability, hydrogels display many properties15 that make
them desirable candidates for tissue engineering applica-
tions. One of the most important advantages is their aqueous
environment, which protects cells and sensitive drugs that
can be incorporated in the network for controlled delivery at
the site of injury. The aqueous environment allows trans-
portation of substances, such as nutrients and by-products
from cell metabolism, in and out of the hydrogels.16 Hy-
drogels can also be derivatized with functional groups that
mediate processes such as cell attachment and subsequent
spreading.17 Until recently, hydrogels have been mainly
considered for soft tissue regeneration. In the last few years,
however, the interest to test the feasibility of using the ben-
eficial properties of hydrogels for hard tissue regeneration
has increased. Still, for applications in hard tissue engineer-
ing, hydrogels are associated with a number of disadvan-
tages such as their poor mineralization upon implantation.18
Further, the inherent mechanical weakness of hydrogels is a
limiting factor that restricts their use to non-load-bearing
applications15,19, even though reinforcement can be achieved
by the addition of other phases.6,18,20,21 Finally, many hy-
drogels are difficult to sterilize due to their high water con-
tent and the polymer reactivity under UV light.22
It is not in the scope of this study to review a list of all the
hydrogels—natural or synthetic—used in the field of tissue
engineering, since there are many excellent reviews that
thoroughly elaborate on this subject.19,23–28 This article will
focus on the strategies developed during the past decade to
induce mineralization in inert, nonmineralizing hydrogels
in vitro (immersion in simulated body fluids [SBF]) or in vivo
for use in bone regeneration. Three major strategies used for
calcification of hydrogels will be reviewed, including (1) the
addition of inorganic particles aiming at mineralization and
improvement of the mechanical properties of hydrogels, (2)
the creation of nucleation sites by biomimetic methods, such
as soaking treatments and the use of enzymes and vesicles
that play an important role in physiological biomineraliza-
tion, and (3) the derivatization of the polymeric hydrogel
backbone with anionic functional groups. In addition, some
indirect methods of mineralization such as growth factors
and cell incorporation or addition of demineralized bone
matrix will be briefly discussed.
Mineralization by Adding Inorganic Phases
The capacity of a specific class of bone-substituting ma-
terials to induce calcification is often referred to as bioac-
tivity, which implies that these materials possess the capacity
to promote nucleation and subsequent proliferation of cal-
cium phosphate crystals. Generally, most polymeric materi-
als do not possess this capacity, but the addition of a ceramic
phase can still render the resulting composites bioactive by
providing nucleation sites for the promotion of hydroxyap-
atite (HA) precipitation. The concept of combining a hydro-
gel with an inorganic phase is inspired by the composite
nature of bone itself. One of the many advantages of adding
an inorganic phase is that the dispersed mineral will provide
nucleation sites for HA formation as well as cell adhesion
sites that enable integration with surrounding bone tis-
sue.29,30 Further, degradation of the temporary hydrogel
implant will allow for replacement by new bone formation,
thus increasing mechanically stability.
Degradation times and mechanical properties of organic–
inorganic composite materials can be controlled to a large
extent by the addition of inorganic phases.20,21,31 Moreover,
the handling characteristics of such composite materials can
be greatly improved, since brittle ceramic particles can be
delivered in moldable or even injectable formulations using
the elasticity of the hydrogels.5 Finally 32, the addition of
carbonated apatites in polymers can have a neutralizing ef-
fect on the acidic pH caused by the degradation by-products,
thus minimizing excessive inflammation around the im-
plantation site.
There are many bioactive inorganic materials that can be
used to render hydrogels mineralizable. These ceramic ma-
terials are able to create a firm bond with bone at the site of
implantation by forming an intermediate layer of HA on
their surface.33
The most commonly used inorganic phases are calcium
phosphates and bioglasses. Many calcium phosphate ce-
ramics can be found in literature with the most representa-
tive being b-tricalcium phosphate (b-TCP), amorphous
calcium phosphate, and HA. This group of ceramics shows
strong resemblance to the mineral phase of bone and it is
found in many normal or pathological calcified sites in the
human body.34 Thorough reviews of all relevant calcium
phosphates that are present in the human body can be found
elsewhere.35–37 Bioactive glasses are amorphous solids con-
taining <60wt% SiO2 that are bioactive due to their high
reactivity in aqueous media. Modern preparation techniques
such as the sol–gel process have yielded a wide range of
mesoporous, highly bioactive, and bioresorbable materials
for the production of bone implants.38 It has been shown39,40
that the formation of HA on the surface of these materials is
due to the formation of –OH groups when the glass contacts
body fluids.41,42
Composites based on natural hydrogels
Advantages of natural hydrogels include their biocom-
patibility, biodegradability, and commercial availability.
Composites of natural hydrogels and bioactive phases have
been shown to accelerate osteogenesis and sometimes pos-
sess osteoconductive properties that were even superior to
monolithic HA implants.43 There are many natural poly-
mers23 used for tissue engineering most commonly collagen
and its denatured derivative gelatin44, fibrin, as well as chitin
and its deacetylated derivative chitosan.
Collagen (mostly collagen type I) is the main polymer
phase of bone,45 and it is highly biocompatible, degrades
enzymatically, and can be processed easily into different
forms such as sponges,46 fibers,47 tubes, and sheets.48,49 An
example of a collagen hydrogel that was combined with an
inorganic calcium phosphate phase was reported by Zou
et al.49 The collagen fibers were crosslinked by using glu-
taraldehyde. Ceramic b-TCP particles were homogeneously
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dispersed inside the collagen matrix, but also a firm bond
between the ceramic particles and the hydrogel was formed.
In addition, the scaffolds showed bone tissue regeneration
after 12 weeks of implantation in animals. For more spe-
cific information on the use of collagen as matrix phase,
the reader is referred to a thorough review about collagen-
HA composites for hard tissue engineering by Wahl and
Czermuszka.50
Fibrin glue51,52 is a synthetic analogue of the blood coagu-
lation process that creates a fibrin clot upon mixing of the two
components fibrinogen and thrombin and it can be used as
tissue adhesive in many surgical applications due to its fa-
vorable biological behavior. Le Nihouannen et al.53 combined
these beneficial properties of fibrin glue in terms of clinical
handling and biocompatibility with the bioactive characteris-
tics of an additional ceramic phase to develop a composite
material for bone regeneration. Micro- and macroporous
biphasic calcium phosphate granules (HA and b-TCP in a
weight ratio of 60/40, respectively) were mixed with a fibrin
gluematrix inducingmineralizationwithin the fibrin network.
Tan et al.54 prepared an injectable biomaterial consisting of
calcium alginate and nano-HA. The injectability and the
setting time of the material could be easily tuned by altering
the absolute and relative concentrations of the components.
Alginate has the unique capacity to gel in the presence of
dissolved calcium ions, which is a very mild method to
create crosslinks into an organic matrix. The particles of HA
had a diameter of 50 mm and the final concentration of HA in
the gel was kept at 3% g/mL. CaSO4 was used to crosslink
the alginate gel. It was concluded that that the final com-
posite material is a good candidate for bone repair and bone
tissue engineering. Alginates for bone reconstruction re-
inforced with HA55 and octacalcium phosphate56 have also
been shown to be bioactive.
Addition of SiO2, which is the main component of bio-
glasses, inside polymeric matrices also aims to trigger the
calcification of polymer matrix. Madhumathi et al.57 pre-
pared a scaffold by dispersing silica nanoparticles inside a
chitin hydrogel. The scaffold showed HA formation only
after 7 days of immersion in SBF. Similar particles were also
introduced inside chitosan hydrogels58 and significant min-
eralization of the matrix was observed after immersion in
SBF as well as implantation in rat calvaria for 3 weeks. Si-
milarly, addition of sol-gel prepared SiO2-CaO-P2O5 bioglass
nanoparticles inside a chitosan-based hydrogel also induced
bone-like apatite after immersion in SBF.59
Composites based on synthetic hydrogels
Even though naturally derived hydrogels have desirable
biological properties, they often exhibit degradation profiles
that are too fast for hard tissue regeneration.60 Moreover,
chemical characteristics of natural hydrogels such as the
molecular weight usually display a wide distribution due to
their natural origin, which limits the reproducibility and
functionality of the materials. On the contrary, synthetic
hydrogels can be prepared with tailored and highly repro-
ducible chemical characteristics, thereby allowing for careful
degradation properties.61 The combination of the different
monomer units results in hydrogels with controlled charac-
teristics in terms of degradation rate, swelling ratios, and
mechanical properties.62
Polymeric chains can be finely tuned based on the clinical
requirements of the various applications in hard tissue engi-
neering. As a result, a wide range of crosslinking techniques
can be used to form the hydrogels such as photo-
polymerization or radical polymerization in the presence of
small crosslinking agents.10,17,61 The most common synthetic
hydrogels that are studied for bone tissue engineering pur-
poses include hydrogels based either on polyethylene glycol
(PEG)62,63, poly(2-hydroxyethyl methacrylate) (pHEMA), or
poly(N-isopropylacrylamide).64,65
A recent example of the use of PEG-based hydrogels as
matrix for the addition of inorganic HA nanoparticles was
described by Sarvestani et al.,66,67 who exploited the calcium-
binding capacity of a 6-glutamic acid sequence (as found in
the terminal sequences of osteonectin) to increase the inter-
action strength between inorganic HA nanoparticles and
(L-lactide-co-ethylene oxide-co-fumarate). The other end of
the peptide was functionalized with an acrylate group that
enabled the establishment of covalent bonds between the
peptide and the organic polymer. In this way, the functio-
nalized peptide acted as a linker between inorganic and
organic composite components.
Patel et al.68 developed cyclic acetal hydrogels reinforced
with nanoparticles of HA for craniofacial tissue engineering
application. Incorporation of HA nanoparticles into cyclic
acetal hydrogels resulted into enhanced differentiation of
bone marrow stromal cells by promotion of endogenous
osteogenic signal expression.
Composites based on pHEMA with high mineral content
of about 37%–50% were prepared by Song et al.69 The group
used pHEMA polymer that was crosslinked in the presence
of HA crystals using viscous ethylene glycol as solvent to
facilitate the easy dispersion and prevent sedimentation of
the HA particles. Even though the material had a mineral
content similar to that of human bone, it possessed elasto-
meric properties that allowed for press-fitting the composites
into bone defects. After implantation in rats, the material
supported osteoblastic differentiation and promoted bone
mineralization. The combination of the excellent mechanical
properties along with the beneficial biological response,
confirm the promising concept of using pHEMA in combi-
nation with HA crystals. Similarly, pHEMA has been
reinforced with inorganic particles such as such as TiO2 na-
noparticles,70 nanocarbonate-substituted apatite,71 and SiO2
nanoparticles.72
Biomimetic Mineralization
Hydrogels can also be mineralized by means of biomi-
metic methods that take their inspiration from the biomi-
neralization process by which native apatite nanocrystals are
formed in vivo. Several features from this biomineralization
process have been studied for their potential to be used in
hydrogel mineralization, including (alternate) soaking treat-
ments in fluids that are saturated with respect to apatite
deposition, enzyme-directed mineralization, and the incor-
poration of synthetic analogs of matrix vesicles as initial sites
of biomineralization.
Soaking in solutions containing Ca2þ and PO4
3
Du et al.73 used collagen matrices presoaked in PO4
3
that were subsequently immersed in Ca2þ solutions. By
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controlling the parameters of their method, different crystal
polymorphs could be created, whereas the materials were
shown to be able to promote mineralization upon implan-
tation in rats. Furuichi et al.74 prepared a calcium phosphate-
polyacrylic acid composite hydrogel by crosslinking a
polyacrylic acid polymer in the presence of (NH4)HPO4 so-
lution and then immersing it in a calcium containing solu-
tion. The diffusion of Ca2þ into the polyacrylic acid hydrogel
that contained phosphate ions induced calcification of
the hydrogel matrix resulting in a hierarchically organized
composite architecture that resembled bone.
By alternately incubating a cellulose hydrogel in calcium
and phosphate solutions, Hutchens et al.75 was able to prepare
biomimetic composites. The mineral phase of these compos-
ites was characterized as calcium-deficient HA. X-ray dif-
fraction also revealed that the crystallites formed were
elongated along the c-axis and had a length of*50 nm, which
is similar to the apatite crystals found in natural bone. The
samemechanismwas utilized to induce HAmineralization in
a chitosan hydrogel by Madhumathi et al.,76 who used chit-
osan hydrogel membranes that were alternately soaked in
solutions of CaCl2 and Na2HPO4. HA deposits were homo-
geneously dispersed throughout the matrix after five cycles.
Similarly, Hong et al.77 used a cellulose hydrogel that was first
treated with a CaCl2 solution and then immersed in SBF.
Uniform and dense biomimetic mineralization was observed
after immersion for 14 days in the SBF solution.
Using a urea-containing solution, Kim et al. managed to
precipitate calcium phosphate crystals on top and inside a
PEG-based hydrogel.78 The PEG-fumarate polymer was
crosslinked with ethylene glycol methacrylate phosphate,
which acted as a source of phosphorous for the formation of
apatitic crystalline platelets with a ratio of Ca/P equal to 1.60.
Vesicles loaded with Ca2þ and PO4
3
Another aspect of bone biomineralization that has been
exploited to calcify hydrogel matrices relates to the vesicular
nature of physiological calcification. Initial mineralization
occurs in the so-called matrix vesicles, which are cellularly
derived structures of 40–200 nm in diameter that are sepa-
rated from other structures in the extracellular matrix by a
limiting phospholipid membrane enclosing a central aque-
ous core. After their formation in specific regions of the outer
membrane of osteoblasts, these vesicles migrate toward the
calcification front of growing bones. Here, the vesicles secrete
apatitic crystals that subsequently calcify periodically ar-
ranged, calcium-binding hole zones with specific amino acid
composition in collagen fibers of the extracellular matrix.79,80
Liu et al.81 created liquid vesicles that entered the hydrogel
matrix using a current-mediated ion diffusion method that
resulted in mineralization at the interior of a pHEMA hy-
drogel. The dense hydrogel acted as binding site for the Ca
ions and promoted mineralization of nanoapatite. The min-
eral that was formed inside the entire volume of the hydrogel
exhibited a structure very similar to the inorganic component
of bone. A similar strategy to promote mineralization ac-
cording to vesicular mineralization was developed by Ped-
erson et al.82 and Westhaus and Messersmith.83 In the latter
studies the vesicles were designed to melt at body temper-
ature to release the Ca2þ and PO4
3 ions necessary for
mineralization of the surrounding hydrogel matrix.
Enzymatic mineralization
Alkaline phosphatase (ALP) 84 is an enzyme that plays an
important role in the remodeling of bone and more specifi-
cally in the resorption of bone and the mineralization of
carbonated apatite. The enzyme acts as a catalyst for the
hydrolysis of the organic phosphoesters, thereby increasing
the local concentration of inorganic phosphate groups that
results into enzyme-directed deposition of carbonated apa-
tites.85,86 Moreover, ALP decreases the concentration of py-
rophosphates that act as inhibitors of apatite crystal growth.
Recently, several groups have tried to immobilize this en-
zyme onto implant surfaces or into hydrogels to induce local
mineralization of implant surfaces and scaffolds.87
ALP has been immobilized88 onto a fibrin gel by activating
the –COOH groups from fibrin glue using 1-ethyl-3-(di-
methylaminopropyl) carbodiimide hydrochloride. Subse-
quently, these scaffolds were incubated in ALP solutions
resulting in covalent bonding between the enzyme and the
fibrin scaffold. Using a mouse calvarial defect model, it was
demonstrated that the fibrin scaffold with the immobilized
ALP enhanced new bone formation.
Similarly89, ALP has been immobilized onto a pHEMA
hydrogel using a copolymerization technique. The enzyme
retained its activity after copolymerization, and after im-
mersion in SBF containing organophosphates for 17 days,
mineral deposition was observed.
Spoerke et al.90 report the synthesis of a novel gel com-
posed of amphiphilic nanofibers functionally enriched with
phosphorylated and acidic groups. The hydrogels were
formed in the presence of cell culture media supplemented
with calcium chloride and immersed in calcification media
containing b-glycerolphosphate and ALP among others.
After 8 days of immersion the mineralization was visibly
apparent throughout the hydrogel.
Chemical Modification of Hydrogels
A different approach to induce mineralization in hydrogels
involves the introduction of negatively charged functional
groups onto the backbone or side chains of hydrogel poly-
mers. This mechanism resembles the biomineralization pro-
cess in bone tissue, where noncollagenous, calcium-binding
proteins are essential as modulators of nucleation and growth
of apatitic biomineral nanocrystals. Generally, these proteins
are acidic and phosphorylated and accumulate in mineraliz-
ing bone matrix91. Important mineral-inducing proteins such
as osteonectin and bone sialoprotein (BSP) are enriched in
anionic glutamate (Glu).92,93 These acidic sequences are re-
sponsible for the attraction of Ca2þ and subsequent creation of
a local supersaturation that is necessary for CaP precipitation,
whichmake them quintessential for biomineralization of hard
tissues. Similarly, alternating sequences of anionic carboxyl-
ate, phosphate, or hydroxyl groups along the backbone of
synthetic or natural polymers can endow the resulting hy-
drogels in swollen state with apatite-nucleating properties.
Therefore, the implementation of acidic sequences into hy-
drogels opens up new perspectives for the development of
hydrogels with mineral-attracting capacity. The following
section will address the functionalization of hydrogels with
negatively charged groups (PO4
3, COOH, and OH) that are
either present as isolated functional groups or as part of
peptide sequences.
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PO4
3, -COOH, and -OH groups
Addition of negatively charged groups such as phosphate,
carboxylate, and hydroxyl groups is commonly performed
by copolymerization of the hydrogel-forming polymer with
monomers containing one or more of these groups.
Stancu et al.94 developed copolymers of diethyl amino
ethyl methacrylate and methacryloyloxyethyl phosphate
(MOEP), as well as copolymers of MOEP with 1-vinyl-2-
pyrrolidinone and compared the calcification ability of both
types of copolymer. Samples with different phosphate con-
tent were prepared and immersed in SBF for 15 days. The
results revealed that globular mineralization occurred on the
surface of the MOEP-diethyl amino ethyl methacrylate hy-
drogels. The absence of mineral deposition onto the MOEP-
1-vinyl-2-pyrrolidinone copolymers was attributed to the
fact that each calcium ion was double bonded by two
phosphate groups from adjacent MOEP units formed during
copolymerization.
Nuttelman et al.95 coupled ethylene glycol methacrylate
phosphate groups to PEG-diacrylate hydrogels. The polymers
were immersed in human mesenchymal stem cell culture
media that were supplemented with b-glycerophosphate,
which resulted in mineral formation on their surface. The
precipitated mineral was found to resemble biological apa-
tites not only in composition, but also in molecular structure.
Wang et al.96 also modified a PEG hydrogel by copolymeri-
zation with a phosphoester. Upon immersion in osteogenic
media for 3 weeks, extensive mineralization was observed
throughout the three-dimensional network of the copolymer.
The introduction of carboxymethyl groups on the pHEMA
backbone was described by Filmon et al.97,98 The prepared
carboxylated scaffolds were immersed in SBF supplemented
with antibiotics for 15 days. The results showed that min-
eralization was induced only by the functionalized pHEMA-
carboxymethyl hydrogel, whereas the unfunctionalized
pHEMA hydrogels did not display any mineral formation.
Crosslinked pHEMA has also been modified by exposing
carboxylate groups on the surface of the hydrogel using urea
to hydrolyze the 2-hydroxyethyl esters of the polymer by
Song et al.,99 who also prepared libraries of pHEMA-based
hydrogels100 copolymerized with negatively chargedmonomers
in a separate study. Both types of carboxylate-functionalized
hydrogels were reported to induce mineralization after im-
mersion in SBF.
The introduction of hydroxyl-containing silanol (Si-OH)
groups on thermosensitive poly(N-isopropylacrylamide)–
PEG dimethacrylate copolymer is described by Ho et al.101
These silanol groups were introduced to the main polymer
backbone by reacting with trimethacryloxypropyltrimetho-
xysilane (MPS). It was reported102 that MPS could be added
at various concentrations, thereby improving the mechanical
properties of the final hydrogel without altering its lower
critical solution temperature. Similar to carboxylate and
phosphate groups, Si-OH groups present in MPS provided
sites that bound calcium and induced subsequent mineral
deposition upon soaking in SBF.
Peptide-mediated mineralization—acidic peptides
Acidic peptide sequences can be conjugated on a hydro-
gel, but there are also formulations of hydrogels composed of
polymerized polypeptides. The mineralization capacity of a
hydrogel made from crosslinked polyglutamic acid was
studied by Sugino et al.103 The hydrogel samples studied
were injectable and bioresorbable, and after crosslinking they
were treated with different concentrations of CaCl2 solutions
for 24 h at body temperature. Upon soaking in SBF for 7
days, HA was formed on the surface of the treated hydrogels
irrespective of the CaCl2 concentration of the solution used
for the pretreatment.
The HA nucleation potency of BSP-collagen hydrogels was
tested and comparedwith agarose-BSP gels by Baht et al.104 To
assess the mineralization potency, the hydrogel scaffolds were
perfusedwith buffers containing either Ca(NO3)2 or Na2HPO4
with a steady flow state. The results showed that collagen
favors the BSP nucleation potency by nearly a factor of 10
when compared to agarose gels. The synergistic interaction
between collagen and BSP appeared to improve the mineral-
ization capacity of these natural hydrogels.
Chirila et al.105 immobilized three different artificial protein
sequences onto pHEMA hydrogels. These sequences (two of
them can be found in nacrein and the third is present in dentin
matrix acidic phosphoprotein) were tested in vitro and their
ability to nucleate calcium phosphate was assessed in solu-
tions. Disks prepared from the peptide conjugated polymers
were immersed inCa2þ and PO4
3 containingmedia for a total
period of 6 weeks. The peptide sequences were shown to have
no or an enhancing effect on calcium mineralization.
Gungormus et al.106 developed a peptide-based hydrogel
that mediated the formation of HA. The 27 residue peptide
MDG1 self-assembles into a hydrogel by changing its
form when alternating the ionic strength of the solution. By
entrapping ALP in the hydrogel and immersing it in a
b-glycerophosphate solution, mineralization of the hydrogel
was achieved.
Indirect Mineralization
Even though it is not the scope of this review to address
drug or cell delivery systems, it should be emphasized that
hydrogels are often used to deliver osteoinductive growth
factors such as bone morphogenetic proteins, demineralized
bone matrix,107–114 and/or cells,115–125 and in many of these
cases extensive mineralization is observed as a secondary
consequence. According to this mechanism, growth factors
trigger cell signaling pathways that stimulate stem cells in
the direct vicinity of the hydrogel to differentiate into the
osteogenic lineage and produce biomineral. In the case of cell
delivery, cells that have been differentiated into the osteo-
genic lineage are encapsulated directly into hydrogels before
implantation that subsequently calcify the carrier hydrogel.
Introduction of the Arginine–Glysine–Aspartate amino
acid sequence (RGD or Arg-Gly-Asp) is commonly used to
provide attachment and differentiation sites for cells inside
the hydrogels resulting in indirect mineralization.126–128
For further information on mineralization induced by
growth factors release and/or cell encapsulation, the reader
is referred to reviews by Salinas and Anseth,123 Hunt and
Grover,129 and Schmidt et al.130
Conclusions
Traditionally, hydrogels have been considered for soft
tissue regeneration only, but recently successful attempts
have been made to render hydrogels suitable for hard tissue
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regeneration. The highly hydrated nature of hydrogels offers
significant advantages over conventional ceramics and non-
swelling polymers in terms of biocompatibility, biodegra-
dation, drug delivery, and injectability that have not been
exploited so far. Since bone is a highly mineralized tissue, the
lack of mineralization ability of inert hydrogels can be gen-
erally considered as the major stumbling block toward ap-
plication of hydrogels for bone-substituting purposes. This
review provides an overview of recent strategies that have
been explored to calcify hydrogels, including the addition of
bioactive inorganic phases, biomimetic mineralization path-
ways that adopt principles from biomineralization, and the
functionalization of hydrogels with negatively charged
functional groups.
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